Introduction
============

Functional recovery after cerebral infarction is a complex phenomenon that is dependent on brain plasticity. Studies have demonstrated that endogenous neural stem cells (NSCs) proliferate, migrate and differentiate following cerebral infarction, and are involved in regeneration of nervous tissue and recovery of brain function ([@b1-mmr-18-02-1455]--[@b3-mmr-18-02-1455]). NSCs have been the focus of much research; however, the neurobiological mechanisms that control proliferation and differentiation of endogenous NSCs after cerebral ischemia remain unclear.

Physical exercise is widely used as a rehabilitation treatment for promoting sensory and motor function recovery in patients after stroke. The recovery mechanisms are generally believed to be associated with neural plasticity ([@b4-mmr-18-02-1455]). In rats, physical exercise has been demonstrated to reduce infarct volume, promote angiogenesis and induce neurogenesis ([@b5-mmr-18-02-1455],[@b6-mmr-18-02-1455]); in addition, Luo *et al* ([@b7-mmr-18-02-1455]) reported that physical exercise can promote proliferation of NSCs or precursor cells in rat brain tissue. Most studies to date have only observed the effect of physical exercise on NSCs in the hippocampus following cerebral infarction; therefore, further studies are required to better understand the underlying molecular mechanisms.

The role of various signal transduction pathways in the mechanism of cerebral ischemic injury has garnered much attention. Notably, activation of the extracellular signal-regulated kinase (ERK) pathway appears to be implicated in ischemic brain injury ([@b8-mmr-18-02-1455]). Ischemia, hypoxia, growth factors and other factors can lead to activation of ERK, which in turn translocates to the nucleus, and increases the expression of genes associated with cell proliferation and differentiation ([@b9-mmr-18-02-1455],[@b10-mmr-18-02-1455]). It has previously been identified that pre-exercise training can upregulate the ERK signaling pathway and improve neurological function ([@b11-mmr-18-02-1455]); however, it is unknown whether physical exercise following cerebral ischemia can still activate the ERK signaling pathway. At present, there are different views on the timing and mechanism of physical exercise, and physical exercise following cerebral infarction is more in line with clinical practice. Therefore, the present study investigated the effects of physical exercise 24 h after cerebral infarction in rats. The aim was to investigate whether physical exercise could promote proliferation and differentiation of NSCs in the dentate gyrus of rats with cerebral infarction, and improve neurological function by activating the ERK signaling pathway.

Exploring the role of physical exercise and ERK signaling in endogenous NSCs will aid in determining the molecular mechanisms associated with physical exercise, and may explain the specific regulatory mechanism of the ERK signaling pathway. The results may also provide novel targets for clinical rehabilitation, further promote the application of physical exercise in the clinic and provide a more solid theoretical foundation of kinesiotherapy.

Materials and methods
=====================

### Animals

Normal adult male Sprague Dawley rats (250--300 g, 3--4 months old) were provided by the Experimental Animal Center of Southern Medical University (Guangzhou, China). The rats were given enough water and food every day at 22°C, 3--5 rats per cage. Procedures involving animals and their care were conducted in accordance with National Institute of Health (NIH) guidelines (NIH pub. no. 85-23, revised 1996), and the present study was approved by the Animal Care and Use Committee of the Southern Medical University (Guangzhou, China).

### Middle cerebral artery occlusion (MCAO) model

Rat cerebral ischemia reperfusion injury was performed according to the Longa method of MCAO ([@b12-mmr-18-02-1455]). Rats were anesthetized by intraperitoneal injection of 10% chloral hydrate (400 mg/kg). The skin on the neck was shaved, sterilized and a 2 cm midline incision was made. The right carotid artery, external carotid artery and internal carotid artery were identified and carefully separated. Subsequently, the external carotid artery and common carotid artery near the heart were ligated. Briefly, suture thread was inserted through the carotid artery into the internal carotid artery for a distance of 19±0.5 mm until resistance was felt, to occlude the origin of the MCA. Following 2 h, the suture was withdrawn to allow reperfusion. In the sham surgery group, rats were processed in the same way as the MCAO group, however vessels were not ligated and no occlusion suture was inserted. Following completion of the operation, rats were placed in clean housing for recovery. All procedures were performed under aseptic conditions.

### Verification of the MCAO model

To verify the reliability and reproducibility of the MCAO model using the Longa method, triphenyl tetrazolium chloride (TTC) staining was performed to detect brain lesions in two rats that were randomly selected from the MCAO group. Firstly, rats were anesthetized with 10% chloral hydrate (500 mg/kg) and the heart was then exposed. An infusion needle was inserted through the left ventricle to cannulate the aorta and cut the right atrium, the blood was flushed by perfusion with \~500 ml saline. Once the liquid was clear, the rats were decapitated; the brain was dissected, placed in the refrigerator of −20°C for quick freezing 20--30 min and placed in a customized slicer to cut 2 mm coronal sections. Sections were incubated in 2% TTC solution at 37°C in the dark for 30 min and then removed. The stained sections were photographed immediately.

### Inclusion criteria and experimental groups

Rat neurological findings following MCAO were evaluated using the Longa scoring method ([@b12-mmr-18-02-1455]): 0, no neurological deficit; 1, failure to extend left forepaw fully indicating mild neurological deficit; 2, circling to the left indicating moderate focal neurological deficit; 3, falling to the left indicating severe focal deficit; and 4, no spontaneous walking and depressed level of consciousness. Animals with scores of 1--3 were included in the present study.

Rats were randomly divided into the physical exercise group (E; n=27), the physical exercise group receiving U0126, a mitogen-activated protein kinase kinase (MEK) 1/2 inhibitor that blocks ERK signaling (EU; n=27), the control group (MCAO but untreated) (C, n=27), the control group treated with U0126 (CU; n=27), and the sham surgery group (S; n=27). These five groups were further divided into three subgroups with time points of 7, 14 and 21 days after MCAO.

### Physical exercise

The E and EU groups underwent treadmill adaptation exercise training on an electric treadmill (length, 45 cm), 2 days prior to the MCAO surgery. Rats in each group were housed in standard cages after surgery (n=3--5 rats/cage). Rats in the C, CU and S group were fed *ad libitum*, and allowed to move freely in the cage. Rats in the E and EU group began exercise training 24 h after MCAO surgery. The treadmill was not inclined and was set to a speed of 10--20 m/min; and the rats ran 30 min/day five times a week. Animals were sacrificed at the respective time points for tissue analysis.

### Neurological severity scores

Modified neurological severity score (mNSS) tests were used to assess the neurological function of the rats in each group at 7, 14 and 21 days after MCAO surgery ([@b13-mmr-18-02-1455]). There were six items in the mNSS test: Spontaneous activity test, a paresis test, a forelimb motor function test, a motor function test, and tests for pain sensation and deep sensation, with a total score of 18. The neurological function was graded on a scale of 0--18: 13--18 indicated severe injury, 7--12 indicated moderate injury and 1--6 indicated mild injury. The tests were performed blind and in triplicate, and the average score was recorded.

### 5-bromodeoxyuridine (BrdU) administration and tissue collection

A total of 3 days prior to tissue collection, rats in each group were intraperitoneally injected with BrdU (50 mg/kg; Sigma-Aldrich; Merck KGaA, Darmstadt, Germany) three times a day at 8 h intervals (for 2 days). Animals were sacrificed 24 h after the last injection. U0126 (Cell Signaling Technology, Inc., Danvers, MA, USA) was dissolved in dimethyl sulfoxide, diluted to 0.5 mg/ml in PBS, and injected into the tail vein of CU and EU rats (0.5 mg/kg) 30 min prior to MCAO surgery.

Rats were anesthetized with 500 mg/kg 10% chloral hydrate via intraperitoneal injection. The chest was opened to expose the heart, and the brain was fixed by cardiac perfusion with 4% paraformaldehyde in PBS for 24 h at 4°C. Brains were dissected following decapitation, and the right hemispheres were paraffin-embedded. Paraffin blocks were serially sliced in the coronal plane into 5-µm sections; every fifth section was used for staining.

### Hematoxylin and eosin (H&E) staining

H&E staining was used to detect MCAO-induced lesions at the respective time points. Deparaffinization of tissue sections was achieved by conventional xylene dewaxing, ethanol removal of xylene and washing in distilled water for 2 min. The sections were placed in hematoxylin for 1 min, washed in water for 1 min, differentiated in 1% hydrochloric acid ethanol for 10--30 sec, washed in water for 20 min, placed in eosin for 5--10 min all at room temperature and then dehydrated using an ethanol gradient. The sections were fixed with neutral balata for 12--24 h at room temperature and visualized under a light microscope.

### Immunofluorescence staining

Immunofluorescence staining was used to detect BrdU^+^/neuronal nuclei (NeuN)^+^ and BrdU^+^/glial fibrillary acidic protein (GFAP)^+^ cells in the hippocampal dentate gyrus at 7, 14 and 21 days after MCAO surgery. Deparaffinized sections were incubated in 3% H~2~O~2~ in methanol solution for 10 min and then trypsin-digested for 10 min at 37°C. Subsequently, the sections were microwaved in citrate buffer (pH 6.0) for antigen retrieval and blocked with normal goat serum (Boster Biotechnology, Inc., Wuhan, China) for 10 min at 37°C. The sections were incubated at 4°C overnight with the following primary antibodies: Mouse anti-BrdU (1:100; cat. no. B2531; Sigma-Aldrich; Merck KGaA), rabbit anti-NeuN (1:200; cat. no. ab177487) and rabbit anti-GFAP (1:500; cat. no. ab7260; both Abcam, Cambridge, MA, USA). Following a wash step in PBS, the sections were incubated with secondary antibodies for 1 h at 37°C: Cy3 goat anti-mouse IgG (1:300; cat. no. TA130012; OriGene Technologies, Inc., Beijing, China) and Alexa Fluor 488 goat anti-rabbit IgG (1:400; cat. no. ab150077; Abcam). Lastly, DAPI (cat. no. D9542; Sigma-Aldrich; Merck KGaA) was added for 10 min at room temperature, sections were washed in PBS and mounted in 50% glycerol. Negative controls were generated by replacing the primary antibodies with PBS. Sections were examined using an Olympus inverted microscope, and five non-overlapping visual fields were selected at random. Images were analyzed using Image-Pro Plus version 6.0 (Media Cybernetics, Inc., Rockville, MD, USA), and the number of BrdU^+^/NeuN^+^ and BrdU^+^/GFAP^+^ cells/mm^2^ of hippocampal dentate gyrus slice was counted.

### Western blot analysis

Western blotting was used to detect cyclin-dependent kinase 4 (CDK4), Cyclin D1, retinoblastoma protein (p-Rb), P-16, phosphorylated (p)-ERKl/2 and c-Fos protein expression in the hippocampus 7, 14 and 21 days after MCAO surgery. To extract proteins, the hippocampus was incubated in RIPA lysis buffer (Beyotime Institute of Biotechnology, Haimen, China). The sample was centrifuged and the supernatant was harvested for protein quantification using bicinchoninic acid assay. A total of 50 µg proteins were separated by 12% polyacrylamide gel electrophoresis and transferred onto a polyvinylidende difluoride membrane. 5% skimmed milk powder was incubated with the membrane at room temperature for 2 h. Membranes were incubated at 4°C overnight with antibodies against: CDK4 (1:1,000; cat. no. ab199728; Abcam), Cyclin D1 (1:1,000; cat. no. 2978), p-Rb (1:1,000; cat. no. 8516; both Cell Signaling Technology, Inc.), P-16 (1:1,000; cat. no. ab54210; Abcam), ERK (1:1,000; cat. no. 4695), p-ERK (1:2,000; cat. no. 4370; both Cell Signaling Technology, Inc.), c-Fos (1:4,000; cat. no. ab134122; Abcam) or β-actin (1:1,000; cat. no. 4970; Cell Signaling Technology, Inc.). Subsequently, the membranes were washed and incubated with HRP-conjugated goat anti-rabbit IgG antibody (1:2,500; cat. no. TA140003; OriGene Technologies, Inc. Beijing, China) for 1 h at 37°C. Proteins were visualized and analyzed by the Bio-Rad ChemiDoc™ XRS+ gel imaging system (Bio-Rad Laboratories, Inc., Hercules, CA, USA) and the software is ImageJ v1.8 (National Institutes of Health, Bethesda, MD, USA). Protein expression was normalized against the internal reference protein, β-actin.

### Statistical analysis

Statistical analyses were conducted using SPSS version 20.0 software (IBM Corp., Armonk, NY, USA). All values were expressed as the means ± standard deviation. The experiments were repeated three times. One-way analysis of variance was used to determine whether there was a statistically significant difference between multiple groups. The Levene\'s test was used to assess the equality of variances. If the variance was homogeneous, the Fisher\'s least significant difference test was used and if the variance was not homogeneous the Dunnett\'s test was used. P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

### Preparation of the MCAO model

TTC staining of the rat brains confirmed that the MCAO was successfully established. As shown in [Fig. 1A](#f1-mmr-18-02-1455){ref-type="fig"}, MCAO generated infarction in the brain, which was indicated by a pale white color. Conversely, normal brain tissue was pink in color, indicating living tissue.

### Functional assessment

The mNSS scores were zero for the S group at all time points. The mNSS score for the E group was significantly lower compared with in the C and CU groups 7 days following MCAO surgery (P\<0.05), and although the score was also lower than in the EU group, significance was not reached. At 14 and 21 days after MCAO, the E group had a significantly lower mNSS score compared with all other experimental groups (P\<0.05). The mNSS score of the C group was significantly lower compared with in the CU group 14 and 21 days after MCAO (P\<0.05; [Fig. 1B](#f1-mmr-18-02-1455){ref-type="fig"}).

### Pathological alterations

H&E staining ([Fig. 2](#f2-mmr-18-02-1455){ref-type="fig"}) revealed that the cells in the cerebral cortex and hippocampus of the S group were large and neatly arranged, with distinct nuclear membranes and nucleoli. In addition, the nucleus was located in the center of the cells, and the tissue was intact.

In the C, CU and EU groups, the right cerebral cortex and hippocampal area contained ischemic lesions, tissue edema, cell degeneration and necrosis. The normal morphology of some neurons was lost. The cytoplasm, nuclear membrane and nucleoli appeared abnormal, with deeply stained nuclei and nuclear condensation.

Pathological alterations were alleviated in the E group. The nerve cells were generally neatly arranged, with normal cell size and morphology. The cytoplasm was stained blue and the nucleoli were clear.

### Expression of BrdU^+^/NeuN^+^ cells in the hippocampal dentate gyrus

The majority of cells in the S group were BrdU^−^/NeuN+, indicating that proliferation was minimal; only a small number of BrdU+/NeuN+ cells were observed in some brain slices. The number of BrdU+/NeuN+ cells in the E group was significantly higher compared with in the C and CU groups 7 days after MCAO (P\<0.05); and the number of cells was also higher compared with the EU group, however there was no statistically significant difference. The E group demonstrated a significant increase in the number of BrdU+/NeuN+ cells compared with all other groups 14 and 21 days after MCAO surgery (P\<0.05). The number of cells in the C group was significantly higher than the CU group at 14 and 21 days after MCAO (P\<0.05; [Fig. 3](#f3-mmr-18-02-1455){ref-type="fig"}).

### Expression of BrdU^+^/GFAP^+^ cells in the hippocampal dentate gyrus

Most cells in the S group were BrdU^+^/GFAP^+^ with only a small number of BrdU^+^/GFAP^+^ cells observed in some brain slices. The E group had a significant increase in the number of BrdU^+^/GFAP^+^ cells 7, 14, and 21 days after MCAO (P\<0.05), indicating proliferating astrocytes. The number of cells in the C group was significantly higher compared with in the CU group 14 and 21 days after MCAO (P\<0.05; [Fig. 4](#f4-mmr-18-02-1455){ref-type="fig"}).

### Western blot analysis

The expression levels of Cyclin D1 in the E group were significantly increased at all time points compared with in the other groups (P\<0.05). The expression levels of CDK4 and p-Rb in the E group were significantly increased 14 and 21 days compared with in the other groups (P\<0.05). Although the expression levels of CDK4 and p-Rb in the E group were increased at 7 days compared with in the C group, the difference was not statistically significant. The expression levels of Cyclin D1, CDK4 and p-Rb in the C group were significantly higher compared with the CU group 7, 14, and 21 days after MCAO (P\<0.05). The expression levels of P-16 in the E group were significantly lower at 14 days compared with in the other groups (P\<0.05), and the expression levels of P-16 in the E group were lower at 7 and 21 days compared with in the C group, but the difference was not statistically significant. The expression levels of P-16 in the C group were significantly lower than in the CU group 7 and 14 days after MCAO (P\<0.05; [Fig. 5](#f5-mmr-18-02-1455){ref-type="fig"}).

The expression levels of p-ERK1/2 and c-Fos in the E group were significantly increased at each time point compared with in the other groups (P\<0.05). The expression levels of c-Fos in the C group were significantly higher compared with in the CU group 7, 14, and 21 days after MCAO (P\<0.05). The expression levels of p-ERK1/2 in the C group were significantly higher compared with in the CU group 7 and 21 days after MCAO (P\<0.05; [Fig. 6](#f6-mmr-18-02-1455){ref-type="fig"}).

Discussion
==========

Studies have demonstrated that physical exercise serves an important role in recovery of neurological function in patients with cerebral infarction ([@b14-mmr-18-02-1455]--[@b16-mmr-18-02-1455]). The rehabilitation mechanism of physical exercise is widely believed to be associated with neural plasticity, and may be related to the regulation of differentiation and proliferation of endogenous NSCs; however, the molecular mechanisms still need to be clarified.

BrdU is a thymine nucleotide analog that is incorporated into DNA during the S phase of the cell cycle and is a commonly used marker for cellular proliferation ([@b17-mmr-18-02-1455]). Zhang *et al* ([@b18-mmr-18-02-1455]) demonstrated that this is a common method for detecting NSCs. Previous studies have demonstrated that the presence of increased numbers of BrdU^+^ cells identified the proliferation of NSCs ([@b19-mmr-18-02-1455],[@b20-mmr-18-02-1455]). In the present study, proliferating cells were visualized by immunofluorescence double staining. BrdU^+^/NeuN^+^ and BrdU^+^/GFAP^+^ cells identified proliferating neurons and proliferating astrocytes, respectively. Due to the presence of increased numbers of BrdU^+^/NeuN^+^ and BrdU^+^/GFAP^+^ cells, and decreased mNSS scores in the E group, it may be hypothesized that physical exercise enhances the proliferation and differentiation of endogenous NSCs to improve the neural function of rats with cerebral infarction. Injection of U0126, an ERK signaling pathway inhibitor, suppressed the proliferation of neural cells and affected the mNSS score. The experimental results demonstrated that physical exercise not only promoted differentiation of endogenous NSCs into neurons, but also their differentiation into astrocytes. It is thought that astrocytes develop a scar around the ischemic region, thereby hindering the growth of new neurons; however, growing evidence suggests that activated astrocytes can inactivate excitatory glutamate and secrete nerve growth factor (NGF), which supports neural cell survival and axon growth ([@b21-mmr-18-02-1455]). Only live astrocytes can support extension of axonal growth cones, thus potentially compensating for injured nerve cells ([@b22-mmr-18-02-1455],[@b23-mmr-18-02-1455]). According to the mNSS results, astrocytes may have a role in endogenous neuroprotection and neural recovery after cerebral ischemia, but the mechanisms need to be further studied.

Clinical and animal studies have revealed that physical exercise can promote nerve regeneration ([@b24-mmr-18-02-1455]--[@b27-mmr-18-02-1455]). Ferreira *et al* ([@b28-mmr-18-02-1455]) demonstrated that short-term and moderate treadmill exercise in rats with cerebral infarction improves hippocampal plasticity, and Brandt *et al* ([@b29-mmr-18-02-1455]) identified that physical exercise promotes the proliferation of NSCs and maturation of neurons in the dentate gyrus of rats, which are in line with the results obtained in the present study. BrdU labeling of proliferation is affected by dose, frequency and other factors. In our previous experiment, BrdU was injected 1 day prior to animal sacrifice ([@b30-mmr-18-02-1455]), marking fewer proliferative cells, whereas daily injection of BrdU may exert potential toxicity in differentiating stem cells ([@b7-mmr-18-02-1455]). Therefore, in the present study, BrdU was injected 3 days prior to animal sacrifice, to mark cell proliferation and avoid toxicity; however, whether this injection scheme is the best remains to be determined.

The proliferation of endogenous NSCs is defined by cells entering the next phase of the cell cycle from the resting G~0~ phase. Cell cycle proteins, including cyclins and CDKs, can control the progression of cells through the cell cycle by forming a complex, thereby initiating activation. Conversely, CDK inhibitors (CKIs) suppress CDK activity and act as negative regulators ([@b31-mmr-18-02-1455]). For example, Cyclin D1 and CDK4 can form a complex known as Cyclin D1/CDK4, which phosphorylates substrate protein p-Rb to drive cells through the cell cycle G~1~/S checkpoint. The CKI, P-16, binds to CDK4 and blocks its interaction with Cyclin D1, resulting in inhibition of p-Rb phosphorylation, as well as inhibition of cell proliferation ([@b32-mmr-18-02-1455]). The results presented in this study revealed that physical exercise upregulated the expression of CDK4, Cyclin D1 and p-Rb, but downregulated the expression of P-16. The use of U0126 inhibited the induction of cell proliferation-associated proteins by physical exercise. Therefore, it may be hypothesized that physical exercise promotes progression of NSCs from the G~0~/G~1~ to S phase by regulating cell proliferation-related protein expression leading to proliferation, with the ERK signaling pathway potentially having an important regulatory role.

ERK is a member of the mitogen-activated protein kinase (MAPK) family. Hypoxia, ischemia, inflammatory cytokines, growth factors, mechanical stress, and biochemical and physical factors can activate the ERK signaling pathway, resulting in a series of phosphorylation processes. The tyrosine kinase receptor Raf-1 binds to Ras and activates the latter, which in turn phosphorylates its downstream substrate MEK. Phosphorylation of MEK activates the downstream phosphorylation of ERK1/2. p-ERK is the active form of ERK that can not only phosphorylate cytosolic proteins, but also transcription factors, including c-Fos, c-Jun, Elk-1 and c-Myc ([@b33-mmr-18-02-1455]). These transcription factors participate in various processes, including cell differentiation, proliferation, inflammation and oxidative stress ([@b34-mmr-18-02-1455]). In cerebral ischemia, the expression and activation of ERK is caused by growth factors, Ca^2+^ influx, oxygen free radicals and excitatory amino acids. ERK is downstream of the NGF receptor and through sequential activation of NGF receptor-Ras-Raf-MEK promotes nerve regeneration ([@b35-mmr-18-02-1455]). Studies have demonstrated that activation of the ERK pathway inhibits neuronal excitotoxicity and serves a neuroprotective role, whereas blocking activation of the ERK pathway promotes cell death ([@b36-mmr-18-02-1455]). Poddar *and Paul* ([@b37-mmr-18-02-1455]) also observed that inhibition of ERK phosphorylation reduces neuronal cell death. Therefore, ERK activation appears to have an important dual role in brain protection and injury.

In rats with spinal cord injury, it has been established that physical exercise activates the ERK signaling pathway leading to regeneration of axons and improved motor function ([@b38-mmr-18-02-1455]). Studies have also demonstrated that electric treadmill training can improve neurological function in rats after cerebral ischemia, which may be related to activation of the ERK signaling pathway; however, the activation pathway remains largely unknown ([@b39-mmr-18-02-1455]). In the present study, it was identified that the protein expression levels of p-ERK1/2 and c-Fos in the E group were higher compared with in the other experimental groups 7, 14 and 21 days after MCAO. When the MEK1/2 inhibitor U0126 was applied, the expression levels of p-ERK1/2 and the downstream protein c-Fos were diminished. These results indicated that physical exercise upregulated the ERK signaling pathway and U0126 blocked the phosphorylation of ERK1/2 caused by physical exercise. This suggested that physical exercise has a positive regulatory role in promoting the proliferation and differentiation of endogenous NSCs via the ERK signaling pathway. Notably, Li *et al* ([@b11-mmr-18-02-1455]) demonstrated that pre-exercise training in mice may upregulate the exercise-induced hormone irisin, which activates the ERK signaling pathway and improves neurological function. The present study identified the potential molecular regulatory mechanisms of physical exercise in improving neurological function after cerebral ischemia in rats, but whether the timing of exercise can also impact activation of the ERK signaling pathway remains to be elucidated in future experiments.

c-Fos is a proto-oncogene, and the rapid and transient expression of the c-Fos protein can be induced by ischemia, hypoxia, injury and drug action. c-Fos is a transcription factor that regulates the expression of downstream target genes. It is involved in an array of important biological processes, including cell proliferation, differentiation, survival and regulation of axon elongation ([@b40-mmr-18-02-1455],[@b41-mmr-18-02-1455]). Studies have demonstrated that low frequency electrical stimulation can induce the expression of c-Fos to improve neurological function ([@b42-mmr-18-02-1455]). In addition, it has been reported that high levels of c-Fos serve an important role in the differentiation and maturation of cerebellar granule neurons ([@b43-mmr-18-02-1455]). c-Fos can also promote the expression of NGF to enhance neuronal repair ([@b44-mmr-18-02-1455]), accelerate the reconstruction of neural networks and promote neuritis ([@b45-mmr-18-02-1455]). Certain studies have identified that physical exercise promotes the expression of c-Fos in the hippocampus of rats, and may be associated with age and exercise intensity ([@b46-mmr-18-02-1455],[@b47-mmr-18-02-1455]). However, c-Fos has been linked to apoptosis ([@b48-mmr-18-02-1455]); therefore, there has been some controversy over whether c-Fos is protective or damaging in cerebral ischemia. The results of the present study revealed that physical exercise increased the expression of c-Fos and improved neurological function in rats, and that treatment with U0126 inhibited c-Fos expression. These results indicated that c-Fos may be involved in regulating the proliferation and differentiation of NSCs, and that physical exercise can upregulate the expression of c-Fos to protect brain cells.

There are some limitations to the present study. Firstly, the experiments only utilized one exercise regime, and whether or not exercise type, intensity, duration and time of intervention could have different effects on activation of the ERK signaling pathway remains to be determined. Secondly, the experiments revealed that U0126 did not completely inhibit proliferation and differentiation of endogenous NSCs, suggesting that other signaling pathways may be involved. These questions will be explored in future experiments.

In conclusion, the present study demonstrated that physical exercise increased the number of BrdU^+^/NeuN^+^ and BrdU^+^/GFAP^+^ cells in the hippocampus of rats following cerebral infarction. Physical exercise promoted proliferation and differentiation of endogenous NSCs via the ERK signaling pathway by upregulating the expression of CDK4, Cyclin D1 and p-Rb, but downregulating the expression of P-16, to improve neurological function. These results will aid further understanding of the mechanisms underlying the beneficial neurological effects of exercise and may provide a theoretical basis for clinical rehabilitation.
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![mNSS following MCAO. (A) Representative coronal sections of triphenyltetrazolium chloride staining of brain tissue isolated from the sham and MCAO groups, 24 h following surgery. (B) Neurological function was evaluated by mNSS 7, 14 and 21 days after MCAO. Data are presented as the means ± standard deviation. \*P\<0.05 vs. C; ^\#^P\<0.05 vs. EU; ^&^P\<0.05, ^&&^P\<0.001 vs. CU. C, control group; CU, control group treated with U0126; E, physical exercise group; EU, physical exercise group treated with U0126; MCAO, middle cerebral artery occlusion; mNSS, modified neurologic severity score.](MMR-18-02-1455-g00){#f1-mmr-18-02-1455}

![Hematoxylin and eosin staining of the (A) hippocampal dentate gyrus and (B) cerebral cortex, 7 days after MCAO. C, control group; CU, control group treated with U0126; E, physical exercise group; EU, physical exercise group treated with U0126; MCAO, middle cerebral artery occlusion; S, sham surgery group.](MMR-18-02-1455-g01){#f2-mmr-18-02-1455}

![Exercise enhances proliferation of neurons in the hippocampal dentate gyrus. (A) Immunofluorescence staining for BrdU (red) and NeuN (green) in rats 21 days after MCAO. Scale bar=50 µm. (B) Quantification of BrdU^+^/NeuN^+^ cells 7, 14 and 21 days after MCAO. Data are presented as the means ± standard deviation. The arrows in the images are indicating BrdU^+^/NeuN^+^ cells. \*P\<0.05, \*\*P\<0.001 vs. C; ^\#\#^P\<0.001 vs. EU; ^&^P\<0.05, ^&&^P\<0.001 vs. CU. BrdU, bromodeoxyuridine; C, control group; CU, control group treated with U0126; E, physical exercise group; EU, physical exercise group treated with U0126; MCAO, middle cerebral artery occlusion; NeuN, neuronal nuclei.](MMR-18-02-1455-g02){#f3-mmr-18-02-1455}

![Exercise enhances proliferation of astrocytes in the hippocampal dentate gyrus. (A) Immunofluorescence staining for BrdU (red) and GFAP (green) in rats 21 days after MCAO. Scale bar=50 µm. (B) Quantification of BrdU^+^/GFAP^+^ cells 7, 14 and 21 days after MCAO. The arrows in the images are indicating BrdU^+^/GFAP^+^ cells. Data are presented as the means ± standard deviation. \*P\<0.05, \*\*P\<0.001 vs. C; ^\#^P\<0.05, ^\#\#^P\<0.001 vs. EU; ^&^P\<0.05, ^&&^P\<0.001 vs. CU. BrdU, bromodeoxyuridine; C, control group; CU, control group treated with U0126; E, physical exercise group; EU, physical exercise group treated with U0126; GFAP, glial fibrillary acidic protein; MCAO, middle cerebral artery occlusion.](MMR-18-02-1455-g03){#f4-mmr-18-02-1455}

![Western blot analysis of Cyclin D1, CDK4, p-Rb and P-16 in the hippocampal tissue of rats (A) 7, (B) 14, (C) 21 days after MCAO. Relative expression of (D) Cyclin D1, (E) CDK4, (F) p-Rb and (G) P-16 7, 14 and 21 days after MCAO. Data are presented as the means ± standard deviation. \*P\<0.05, \*\*P\<0.001 vs. C; ^\#^P\<0.05, ^\#\#^P\<0.001 vs. EU; ^&^P\<0.05, ^&&^P\<0.001 vs. CU; ^Δ^P\<0.05, ^ΔΔ^P\<0.001 vs. S. C, control group; CDK4, cyclin-dependent kinase 4; CU, control group treated with U0126; E, physical exercise group; EU, physical exercise group treated with U0126; MCAO, middle cerebral artery occlusion; p-Rb, retinoblastoma protein; S, sham surgery group.](MMR-18-02-1455-g04){#f5-mmr-18-02-1455}

![Western blot analysis of p-ERK1/2, ERK1/2 and c-Fos in the hippocampal tissue of rats (A) 7, (B) 14 and (C) 21 days after MCAO. Relative protein expression of (D) p-ERK1/2 and (E) c-Fos 7, 14 and 21 days after MCAO. Data are presented as the means ± standard deviation. \*P\<0.05 vs. C; ^\#^P\<0.05, ^\#\#^P\<0.001 vs. EU; ^&^P\<0.05, ^&&^P\<0.001 vs. CU; ^Δ^P\<0.05, ^ΔΔ^P\<0.001 vs. S. C, control group; CU, control group treated with U0126; E, physical exercise group; ERK, extracellular signal-regulated kinase; EU, physical exercise group treated with U0126; MCAO, middle cerebral artery occlusion; p, phosphorylated; S, sham surgery group.](MMR-18-02-1455-g05){#f6-mmr-18-02-1455}
